These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1665789)

  • 41. Brain mu and delta opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse.
    Mickley GA; Mulvihill MA; Postler MA
    Psychopharmacology (Berl); 1990; 101(3):332-7. PubMed ID: 2163538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area.
    Calenco-Choukroun G; Daugé V; Gacel G; Féger J; Roques BP
    Psychopharmacology (Berl); 1991; 103(4):493-502. PubMed ID: 1648248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of mu- and delta-opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion.
    Rogers H; Henderson G
    Br J Pharmacol; 1990 Nov; 101(3):505-12. PubMed ID: 1981687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2,D-Pen5]-enkephalin and partial antagonism by naltrindole.
    Cheng PY; Wu DL; Decena J; Cheng Y; McCabe S; Szeto HH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1004-10. PubMed ID: 1326619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
    Crook TJ; Kitchen I; Hill RG
    Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    Mattia A; Vanderah T; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergy between mu/delta-opioid receptors mediates adenosine release from spinal cord synaptosomes.
    Cahill CM; White TD; Sawynok J
    Eur J Pharmacol; 1996 Feb; 298(1):45-9. PubMed ID: 8867918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
    Jewett DC; Mosberg HI; Woods JH
    Psychopharmacology (Berl); 1996 Oct; 127(3):225-30. PubMed ID: 8912400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference.
    Suzuki T; Funada M; Narita M; Misawa M; Nagase H
    Eur J Pharmacol; 1991 Nov; 205(1):85-8. PubMed ID: 1667384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward.
    Duvauchelle CL; Fleming SM; Kornetsky C
    Eur J Pharmacol; 1996 Dec; 316(2-3):137-43. PubMed ID: 8982679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naltrexone-sensitizing effects of centrally administered morphine and opioid peptides.
    Adams JU; Holtzman SG
    Eur J Pharmacol; 1991 Jan; 193(1):67-73. PubMed ID: 1675608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.